The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway

McDaniel SS, Rensing NR, Thio LL, Yamada KA, Wong M (2011). Epilepsia, 52(3):e7-11
Read More

Abstract

The ketogenic diet (KD) is an effective treatment for epilepsy, but its mechanisms of action are poorly understood. We investigated the hypothesis that the KD inhibits mammalian target of rapamycin (mTOR) pathway signaling. The expression of pS6 and pAkt, markers of mTOR pathway activation, was reduced in hippocampus and liver of rats fed KD. In the kainate model of epilepsy, KD blocked the hippocampal pS6 elevation that occurs after status epilepticus. Because mTOR signaling has been implicated in epileptogenesis, these results suggest that the KD may have anticonvulsant or antiepileptogenic actions via mTOR pathway inhibition.

Full Text

 

EmailPrintShare
Posted on October 24, 2011
Posted in: Neurogenetics, Publications Authors: , ,